Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    87,044.95
    +1,065.31 (+1.24%)
     
  • CMC Crypto 200

    1,394.51
    -2.02 (-0.14%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Stocks in play: Orogen Royalties Inc.

Has authorized a grant of 156,000 Restricted Share Units, 156,000 Deferred Share Units and 238,000 Stock Options to independent board members. The grant is pursuant to the Company's Omnibus Equity Incentive Compensation Plan that was approved by shareholders on October 27, 2022, and forms part of part of the independent board's 2023 remuneration. Orogen Royalties Inc. shares V.OGN are trading unchanged at $0.53.

Read: